Immunology
Drug MOA
Rejection
Epidemiology
Drug Side Effects
100

CD8 cells are also known by this name.

Cytotoxic T cell.

100

A pre-metabolite of 6-mercaptopurine, a purine analogue.

Azothioprine

100

This type of rejection occurs after months to years.

Chronic

100

This blood group has the longest wait time on the kidney transplant wait-list

B

100

Most common cancer following transplant.

Skin (squamous)

200

MHC class 1 molecules are found on this type of cell.

All nucleated cells

200

This polyclonal antibody against T-cell antigens is produced in rabbits.

Thymoglobulin

200

This is the treatment for hyperacute rejection.

re-transplantation

200

These are the three most critical HLA alleles in the setting of kidney transplant. (name 2 of 3)

HLA-A, -B, -DR

200

Diarrhea and GI upset are the most common reasons for discontinuation of this anti-metabolite.

Mycophenolate mofetil

300

MHC class 2 molecules activate this type of cell.

CD4 or T helper cells.

300

This macrolide antibiotic binds FKBP, inhibiting the mTOR pathway.

Sirolimus or Everolimus

300

ABO incompatibility leads to hyperacute rejection and this type of hypersensitivity reaction.

Type II

300

These are the two criteria to be placed on deceased donor transplant list.

GFR below 20

Dialysis

300

This calcineurin inhibitor has been known to cause gingival hyperplasia.

Cyclosporine

400

Name 2 things that will increase the percent panel reactive antibody (PRA).

Prior transfusion

Pregnancy

Previous transplant

400

This drug binds cyclophilin, which subsequently binds calcineurin, inhibiting T cell phosphatase activity.

Cyclosporine 

400

This type of rejection is mediated by T-cell reaction to Donor antigens.

Acute rejection (1 week to a couple of months)

400

The number of days post kidney transplant that survival is equal between those transplanted and those on the wait list.

244

400

This agent was recently withdrawn for its side effects of cytokine release syndrome and severe pulmonary edema.

Muromonab-CD3 (OKT3)

500

This interleukin causes maturation of cytotoxic T cells.

IL-2

500

This monoclonal antibody binds IL-2 receptor on T cells inhibiting activation, without causing cell lysis.

Basiliximab

500
Graft fibrosis is the histologic hallmark of this type of rejection.
Chronic
500

These are the 5 absolute contraindications to transplantation. (name 4)

Active substance abuse

Uncontrolled psychosis

Active malignancy

Active infection

Chronic illness with less than 1 year life expectancy

500

This mTOR inhibitor can lead to interstitial lung disease.

Sirolimus

M
e
n
u